Applied DNA Sciences: Q2 Earnings Insights

Shares of Applied DNA Sciences APDN moved higher in after-market trading after the company reported Q2 results.

Quarterly Results

Earnings per share increased 73.42% over the past year to ($0.21), which were in line with the estimate of ($0.21).

Revenue of $2,672,000 higher by 383.64% from the same period last year, which beat the estimate of $2,600,000.

Outlook

Earnings guidance hasn't been issued by the company for now.

Revenue guidance hasn't been issued by the company for now.

Conference Call Details

Date: May 13, 2021

Time: 04:30 PM

ET Webcast URL: https://services.choruscall.com/mediaframe/webcast.html?webcastid=YaMBr3pT

Recent Stock Performance

52-week high: $16.39

Company's 52-week low was at $4.95

Price action over last quarter: down 45.58%

Company Description

Applied DNA Sciences Inc is a provider of DNA-based supply chain, anti-counterfeiting, and anti-theft technology. The company provides its products and services under the brand of SigNature DNA, SigNature T DNA, fiberTyping, DNAnet, digitalDNA, SigNify and Beacon. It serves clients in various industries including government/military, security and asset marking, industrial parts, pharmaceuticals, textiles and apparel, and printing and packaging. The company has operational footprints across the United States, Europe, Asia, and others.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!